Alliance A091802: Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)

Objective

This phase II trial studies how well avelumab with or without cetuximab work in treating patients with skin squamous cell cancer that has spread to other places in the body. Immunotherapy with monoclonal antibodies, such as avelumab and cetuximab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

https://clinicaltrials.gov/ct2/show/NCT03944941

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Studies

Specialty

• Skin Cancer

Contact

Cancer Clinical Trials at 218-786-3308
or cancertrials@essentiahealth.org